CHRISTINE NAPOLITANO
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SCHENECTADY, NY NPI 1770526972
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NY Novo Nordisk AS All categories
General Payments — all program years on this page
$300.14
- Category: General Payments
- Program years: PY2020–2024
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $120.90 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $120.90 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $34.37 | 2 |
| Phathom Pharmaceuticals, Inc. | $27.75 | 1 |
| GlaxoSmithKline, LLC. | $21.13 | 1 |
| Acerta Pharma LLC | $19.59 | 1 |
| Merck Sharp & Dohme Corporation | $18.06 | 1 |
By program year
Records — PY2024 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096684218 | Novo Nordisk Inc | $16.61 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097702520 | Novo Nordisk Inc | $17.76 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104704547 | AstraZeneca Pharmaceuticals LP | $19.59 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116727908 | GlaxoSmithKline, LLC. | $21.13 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141916909 | Merck Sharp & Dohme LLC | $18.06 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151100757 | Phathom Pharmaceuticals, Inc. | $27.75 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.